8KB7

Crystal structure of UDP/mannose-bound AGO61/beta-1,4-N-Acetylglucosaminyltransferase 2 (POMGNT2)

External Resource: Annotation

Protein Family Annotation
Gene Ontology: Gene Product Annotation
InterPro: Protein Family Classification
Pharos: Disease Associations

Protein Family Annotation Pfam Database Homepage

Chains	Accession	Name	Description	Comments	Source
A, B, C, D	PF04577	Glycosyltransferase 61 (Glyco_transf_61)	Glycosyltransferase 61	-	Family

Gene Ontology: Gene Product Annotation Gene Ontology Database Homepage

Chains	Polymer	Molecular Function	Biological Process	Cellular Component
A, B, C, D	Protein O-linked-mannose beta-1,4-N-acetylglucosaminyltransferase 2	UDP-glycosyltransferase activity catalytic activity, acting on a protein glycosyltransferase activity protein O-acetylglucosaminyltransferase activity acetylglucosaminyltransferase activity transferase activity hexosyltransferase activity catalytic activity	developmental process multicellular organismal process neuron migration cellular developmental process nervous system development generation of neurons neurogenesis multicellular organism development cell differentiation anatomical structure development cellular process cell migration cell motility system development developmental process multicellular organismal process neuron migration cellular developmental process nervous system development generation of neurons neurogenesis multicellular organism development cell differentiation anatomical structure development cellular process cell migration cell motility system development carbohydrate derivative biosynthetic process protein mannosylation cellular biosynthetic process cellular metabolic process glycoprotein biosynthetic process carbohydrate derivative metabolic process primary metabolic process glycoprotein metabolic process protein glycosylation macromolecule biosynthetic process biosynthetic process protein O-linked mannosylation glycosylation mannosylation macromolecule modification macromolecule glycosylation protein O-linked glycosylation metabolic process protein metabolic process macromolecule metabolic process protein modification process	membrane-bounded organelle intracellular organelle intracellular anatomical structure organelle endoplasmic reticulum cytoplasm cellular anatomical entity intracellular membrane-bounded organelle endomembrane system organelle subcompartment membrane endoplasmic reticulum subcompartment nuclear outer membrane-endoplasmic reticulum membrane network organelle membrane membrane-bounded organelle intracellular organelle intracellular anatomical structure organelle endoplasmic reticulum cytoplasm cellular anatomical entity intracellular membrane-bounded organelle endomembrane system organelle subcompartment membrane endoplasmic reticulum subcompartment nuclear outer membrane-endoplasmic reticulum membrane network organelle membrane endoplasmic reticulum membrane

InterPro: Protein Family Classification InterPro Database Homepage

Chains	Accession	Name	Type
A, B, C, D	IPR013783	Immunoglobulin-like fold	Homologous Superfamily
A, B, C, D	IPR007657	Glycosyltransferase 61	Family
A, B, C, D	IPR049625	Glycosyltransferase 61, catalytic domain	Domain
A, B, C, D	IPR003961	Fibronectin type III	Domain
A, B, C, D	IPR036116	Fibronectin type III superfamily	Homologous Superfamily

Pharos: Disease Associations Pharos Homepage Annotation

Chains	Drug Target	Associated Disease
A, B, C, D	Pharos: Q8NAT1	muscular dystrophy-dystroglycanopathy, type A limb-girdle muscular dystrophy muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 8 congenital muscular dystrophy subependymal giant cell astrocytoma alpha-Dystroglycanopathies cataract osteosarcoma arthrogryposis hydrocephalus lissencephaly spectrum disorders pituitary cancer attention deficit hyperactivity disorder, inattentive type congenital disorder of glycosylation intellectual disability muscular dystrophy-dystroglycanopathy, type A limb-girdle muscular dystrophy muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 8 congenital muscular dystrophy subependymal giant cell astrocytoma alpha-Dystroglycanopathies cataract osteosarcoma arthrogryposis hydrocephalus lissencephaly spectrum disorders pituitary cancer attention deficit hyperactivity disorder, inattentive type congenital disorder of glycosylation intellectual disability lung adenocarcinoma muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.